SignificantForeign PolicyX (Twitter)·USTR
Today, Ambassador Greer initiated an investigation under Section 301 to assess whether Germany’s persistent underpayment for innovative pharmaceutical products is unreasonable or discriminatory and burdens or restricts U.S. commerce.

Impact Score
6/10
Thursday, June 18, 2026 at 08:54 PM EDT
Read original source →